Aptamer-Functionalized ZIF-8 Nanomedicine for Targeted Delivery of Gefitinib and siRNA to Treat Tyrosine-Kinase-Inhibitor-Resistant Nonsmall-Cell Lung Cancer

Author:

Liu Meng1,Sun Chuanchuan1,Jiang Jiangle1,Wan Li1,Hu Chong1,Wen Chunping1,Huang Guiju1,Ruan Qiufen1,Wu Shuang2,Qiao Dan1,Zheng Pengwu1,Pan Qingshan1ORCID,Zhu Wufu1ORCID

Affiliation:

1. Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, Jiangxi 330013, China

2. Key Laboratory of Jiangxi Province for Persistent Pollutants Control and Resources Recycle, Nanchang Hangkong University, Nanchang 330063, China

Funder

Education Department of Jiangxi Province

Jiangxi University of Science and Technology

Key Science and Technology Research Project in Jiangxi Province Department of Education

National Natural Science Foundation of China

Natural Science Foundation of Jiangxi Province

Jiangxi Science and Technology Normal University

Jiangxi Provincial Key Laboratory of Drug Design and Evaluation

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3